YWHAZ and hepatocellular carcinoma: In a recent study, MIR4435-2HG was found to be highly expressed in HCC tissues; survival time was significantly lower in the high expression group, and MIR4435-2HG was found to compete for the binding of miR-22-3p, thereby promoting the expression of YWHAZ to induce oncogenic effects [30].